Ingestible Sensors in Healthcare Market Size, Share and Industry Analysis, By Component (Sensor, Wearable Patch/ Data Recorder, and Software), By Sensor Type (Temperature Sensor, Pressure Sensor, pH Sensor, and Image Sensor), By End User (Pharmaceutical Companies, Research Institutes, Healthcare Providers, and Others), and Regional Forecast, 2026-2034

Ingestible sensors are non-invasive electronic devices, approximately the size of a medicine capsule, composed of biocompatible materials that aid in diagnosis and monitoring. The device mainly constitutes a power supply, microprocessor, controller, and sensors, enabling telecommunicating for use in the healthcare industry for disease diagnostics and monitoring. The use of these sensors for proper monitoring and management of medications by the geriatric population is expected to increase the ingestible sensors market.

The ingestible sensors market is mainly driven by revolutionizing diagnostics in the forthcoming years and the need to study pH and temperature levels in the body by clinicians and physicians. Strategic initiatives by key players, the growing prevalence of chronic disorders, and the high demand for monitoring and managing patients during treatment are major factors contributing to the adoption of ingestible sensors.

• According to a report published by World Cancer Research Fund International, there was total of 495,773 new pancreatic cancer patients diagnosed in 2020, which is 2.7% of all cancer patients worldwide.
• For example, in November 2019, Seed Health, U.S., announced a research partnership with Atmo Biosciences to evaluate the impact of the world's first ingestible gas-sensing capsule technology in clinical trials to profile key gases produced within the gut in real-time.

Impact of COVID-19 on the Ingestible Sensors Market

As a result, COVID-19 has negatively impacted the ingestible sensors market in 2020, owing to supply chain disruptions and the temporary closure of manufacturing facilities. Research going on smart pills was also delayed due to the pandemic. Regular check-ups were avoided, as the geriatric population and other patients are more prone to infection. However, the market is likely to recover in 2021, owing to new strategies adopted by key players to drive market growth.

• For instance, in September 2020, CapsoVision Inc., announced that the U.S. Food & Drug Administration (FDA) will apply enforcement discretion for at-home administration of the CapsoCam Plus small bowel capsule endoscope during the Covid-19 pandemic for patients eligible for at-home administration.

Key Insights

• New Product Developments
• Impact of COVID-19 on Ingestible Sensors Market
• Technological Advancements in Ingestible Sensors
• Key Industry Developments- Mergers, Acquisitions, And Collaborations

Analysis by Component

In 2021, the software used in ingestible sensors is the prominently growing segment to drive market growth. It provides real-time information on the patient's condition, with the least errors. The launching of new technologies by key players in the market is likely to drive the segment.

• For example, in December 2019, the U.S. FDA approved Gainesville, Florida-based etectRx's ID-CAP System, constituting of ID-Capsule, ID-Tag, ID-Cap Reader, and software. The associated software provides real-time, dose-level data on when the pill is ingested, confirming the patient takes the medication.

Regional Analysis

Request for Customization   to gain extensive market insights.

The ingestible sensors market is expected to grow effectively in North America, owing to the significant technological advancements in the field of endoscopy over the past few years, such as the development of advanced wireless minimally invasive capsule endoscopes. Also, the increasing research for the use of smart pills in detecting gut diseases and others is likely to drive market growth.

• For example, in July 2020, a team of researchers at the University of Saskatchewan, Canada, received a research fund of USD 250,000 for research on an AI-enabled capsule intended for the early diagnosis of gastrointestinal cancers from the federal New Frontiers.

Key Players Covered

• The report will include the profiles of key players such as CapsoVision Inc., Medtronic, etectRx, Intromedic, JINSHAN Science & Technology, Seed Health, HQ Inc., Atmo Biosciences, Proteus Digital Health, Inc., and others.

Segmentation 

• Key Industry Developments

• In May 2022, CapsoVision demonstrated the CapsoCam Plus at Digestive Disease Week (DDW) in San Diego, California, which is the only capsule endoscopy system offering a 360° panoramic view.
• In January 2021, EtectRx, which manufactures medications embedded with wireless sensors, signed a partnership with Pear Therapeutics for developing new technologically advanced products, combining etectRx's medication adherence sensors with Pear's digital therapeutics.
• In March 2019, Olympus Corporation announced the launch of "PowerSpiral" in Europe and parts of the Asia-Pacific region, including Hong Kong and India. The technology uses a motorized rotating attachment that gently grips the mucosa of the small intestine to help the endoscope advance deep into the intestine.